Hi 4s, Great input no doubt you are a very astute with MSB .. You suggested to look at at Maxim Report on 28th January 2013 which hosted a Cadiology Dinner with three world-class Cardiologists and key opinion leaders: Emerson Perin MD, Kenneth M Borrow MD and Warren Sherman MD. The "experts found the high-dose data absolutely compelling when considering all the parameters of cadiac health and cardiac MACE".... And I will do that . thanks ..
(Regarding the 125 patient interim analysis -you said your views are quite the opposite and shows confidence by TEVA with the MPC technology, I agree ... My suggestion is when that interim analysis comes in early 2014 it will have an FDA" fast track" a life saving "push it thu " to save lives this will be the major one for MSB not to forget D2 and a host of stuff coming thu some slip your mind there are so many ,then you find another.. ....Cheers Vin
MSB Price at posting:
$6.63 Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)